HIMS - Hims & Hers cut to Neutral at Citi on recent rally
2024-05-22 07:51:38 ET
More on Hims & Hers Health
- Hims & Hers: Soaring On Access To Compounded GLP-1 Drugs, Further Volatility Ahead
- 10 Solid Reasons To Buy Hims & Hers Stock
- Hims & Hers: Strong Operating Leverage And Profitability Inflection
- Hims & Hers surges on cheap compounded versions of Novo Nordisk's semaglutide
- Hims & Hers surges 11% as 2024 revenue outlook raised, Q1 beats